McLoughlinL, TomlinS, GrossmanA, LytrasN, SchallyAV, CoyD, BesserGM, ReesLH. CRF-41 stimulates the release of B-llpotropin and 8-endorphin in normal human subjects. Neuroendocrinology1984; 38: 282–284.
2.
DentRRM, GuilleminaultC, AlbertLH, PosnerBI, CoxBM, GoldsteinA. Diurnal rhythm of plasma Immunoreactive B-endorphin and its relationship to sleep stages and plasma levels of cortisol and prolactin. J. Clin. Endorcinol. Metab.1981; 52: 942–946.
3.
PetragllaF, FacchinettiF, ParriniO, MiciellG, De LucaS, GenazzaniAR. Simultaneous circadian variations of plasma ACTH, B-endorphin, B-llpotropin and Cortisol. Horm. Res.1983; 17: 147–151.
4.
NakaoK, NakalY, OklS, HorllK, ImuraH. presence of Immunoreactive B-endorphin in normal human plasma A concomitant release of B-endorphin with ACTH after metyrapone administration. J. Clin. Invest.1978; 62: 1395–1399.
5.
PetragllaF, BakalaklsS, FacchinettiF, VolpeA, MüllerEE, GenazzanlAR. Effect of sodium valproate and diazepam on B-endorphin, B-llpotropin and Cortisol secretion induced by hypoglycemic stress in humans. Neuroendocrinology1986; 44: 320–325.
6.
PlotskyPM. Regulation of hypophyslotropic factors mediating ACTH secretion. Ann. N.Y. Acad. Sci.1987, in press.
7.
RivierC, PlotskyPM. Mediation by CRF of adenohyposyal hormone secretion. Ann. Rev. Physiol.1986; 48: 475–492.
8.
KriegerDT, LlottaA, BrownsteinMJ, ZimmermannEA. B-llpotropin and related peptides in brain, pltultray and blood. Rec. Progr. Horm. Res.1980; 36: 377–397.
9.
Clement-JonesV, BesserGM. Opioid peptides in humans and their clinical significance. in: Udenfirnd S, Meyerhofer J (eds) The Peptides, 1984; 6: 323–389.
10.
GenazzaniAR, NapplG, FacchinettiF, MiciellG, PetragilaF, BonoG, MonittolaC, SavoidlF. Progressive Implrment of CSF B-EP levels in migraine sufferers, pain1984; 18: 127–133.
11.
FacchinettiF, SandriniG, PetragllaF, AlfonsiE, NapplG, GenazzaniAR. Concomitant Increase in nociception flexion reflex threshold and plasma opioid following transcutaneous nerve stimulation. Pain1984; 19: 295–303.
12.
SteinbuschHW, NieuwenhysR. Distribution of serotonin-immunoreactivity in the central nervous system and pituitary of the rat with special references to the innervation of the hypothaiamus. Adv. Exp. Med. Biol.1981; 133: 7–35.
13.
PetragllaF, PenalvaA, GenazzanlAR, MullerEE. Stimulation of B-endorphin and B-llpotropin release from the anterior but not the Intermediate pituitary lobe in the rat after acute administration of serotonin acting drugs. Life Sci1982; 31: 2809–2814.
14.
BruniJF, HawkinsKL, YenSSC. Serotoninergic mechanism in the control of B-endorphin and ACTH release in male rats. Life Sci.1982; 30: 1247–1251.
15.
HillhouseIW, BurdeJL, JonesMT. The effect of various putative neurotransmitters on the release of CRH from the hypothalamus of the rat in vitro. Neuroendocrinology1975; 17: 1–8.
16.
PetragliaF, FacchinettiF, MartignoniE, NapplG, VolpeA, GenazzanlAR. Serotoninergic agonists Increase plasma levels of B-endorphin and B-llpotropin in humans. Endocrinology1984; 59: 1138–1142.
17.
FacchinettiF, MartignonlE, NapplG, Marinis, PetragllaF, SandriniG, GenazzanlAR. Ritanser in, a serotonin-S2 receptor antagonist, does not prevent 5-hydorxytriptophan-induced B-EP, B-LPH and Cortisol secretion. Horm. Res.1987; in press.
18.
GenazzaniAR, SandriniG, FacchinettiF, RizzoV, AlfonsiE, SancesG, CalvaniM, NapplG. Effect of I-SHTP with and without carbidopa on plasma B-endorphin and pain perception. Cephaiagia1986; 6: 241–245.
19.
ImuraH, nakalY, YoshimiT. Effect of 5-hydroxytriptophan on GH and ACTH release in man. J. Clin. Endocrinol. Metab.1973; 36: 204–210.
20.
LewisDA, ShermanBM. Serotoninergic stimulation of ACTH secretion in man. J. Clin. Endocrinol. Metab.1984; 58: 458–462.
KriegerDT, RizzoF. Serotonin mediation of clrcadlan periodicity of plasma 17-hydroxycorticosterolds. Am. J. Physiol.1969; 217: 1703–1712.
23.
CavagniniF, magglU, MicossiP, DI LandroA, InvittiC. Effect of antiserotoninergic drug metergoline on the ACTH and Cortisol response to Insulin hypoglycemia and lysin-vasopressin in man. J. Clin. Endocrinol. Metab.1976; 43: 306–311.
24.
BonoG, MiciellG, SancesG, CaivanM, NapplG. I-5HTP treatment in primary headaches: an attempt at clinical Identification of responsive patients. Cephalagla1984; 4: 159–165.
